Kolinpharma SpA
MIL:KIP

Watchlist Manager
Kolinpharma SpA Logo
Kolinpharma SpA
MIL:KIP
Watchlist
Price: 9.9 EUR
Market Cap: €16.2m

Operating Margin

6.9%
Current
No historical data
Comparison unavailable

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
6.9%
=
Operating Income
€970.9k
/
Revenue
€14.1m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
6.9%
=
Operating Income
€970.9k
/
Revenue
€14.1m

Peer Comparison

Country Company Market Cap Operating
Margin
IT
Kolinpharma SpA
MIL:KIP
16m EUR
Loading...
FR
L'Oreal SA
PAR:OR
203.9B EUR
Loading...
UK
Unilever PLC
LSE:ULVR
119.8B GBP
Loading...
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.6T INR
Loading...
UK
HALEON PLC
LSE:HLN
34.1B GBP
Loading...
US
Estee Lauder Companies Inc
NYSE:EL
42B USD
Loading...
DE
Beiersdorf AG
XETRA:BEI
21.2B EUR
Loading...
JP
Kao Corp
TSE:4452
2.8T JPY
Loading...
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.2T INR
Loading...
IN
Dabur India Ltd
NSE:DABUR
912.6B INR
Loading...
CA
Relevium Technologies Inc
XTSX:RLV
12.2B CAD
Loading...

Market Distribution

In line with most companies in Italy
Percentile
43rd
Based on 1 199 companies
43rd percentile
6.9%
Low
-79 476% — 3.9%
Typical Range
3.9% — 14.4%
High
14.4% — 813.7%
Distribution Statistics
Italy
Min -79 476%
30th Percentile 3.9%
Median 8.7%
70th Percentile 14.4%
Max 813.7%

Kolinpharma SpA
Glance View

Market Cap
16.2m EUR
Industry
Consumer products

Kolinpharma SpA engages in the research, development, and marketing of food supplements based on natural raw materials of natural origin. The company is headquartered in Lainate, Milano and currently employs 110 full-time employees. The company went IPO on 2018-03-09. The firm offers a number of products, including almetax, which is a food supplement based on alpha-lipoic acid, L-tryptophan, turmeric, vitamins B5, b6 AND C, Chromium picolinade and Zinc that acts synergistically on the main symptoms of menopause; Almatex easy, which enables the preservation of the general well-being of the body; Dolasix, which is a food supplement that acts synergistically in favor of the normal functionality of cartilages and connective tissues; Ivuxur, which is a food supplement based on cranberry ( dried cranberry extract), D-mannose, bearberry and Zinc that is used in the treatment of unary tract infections; Milesax, which is a food supplement based on magnesium bisglycinate, boswellia serrata and L-tryptophan that acts synergistically on contractures, muscles relaxation and mood during the rehabilitation and recovery phases, and Xinepa, among others.

KIP Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
6.9%
=
Operating Income
€970.9k
/
Revenue
€14.1m
What is Kolinpharma SpA's current Operating Margin?

The current Operating Margin for Kolinpharma SpA is 6.9%, which is in line with its 3-year median of 6.9%.

How has Operating Margin changed over time?

Over the last 3 years, Kolinpharma SpA’s Operating Margin has decreased from 11.5% to 6.9%. During this period, it reached a low of 5.2% on Jun 30, 2022 and a high of 17.8% on Jun 30, 2021.

Back to Top